MSL/Sr. MSL - North Central (IL, MI, MN, NE, ND, SD, WI, IA, PA)

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.

At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.

As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.

To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.

ESSENTIAL JOB FUNCTIONS:

Leverage scientific expertise to establish and maintain strategically impactful relationships with national, regional, and local Acute Myeloid Leukemia (AML) key opinion leaders (KOLs) and other healthcare providers (HCPs) in alignment with medical strategy.

Proactively and reactively engage KOLs and HCPs on a variety of topics inclusive, but not limited to, disease state, mechanism of action, clinical data, and the evolution of the treatment landscape(s).

Support asset-specific prelaunch readiness and optimized launch execution through the attainment of impactful qualitative and quantitative field medical metrics.

Provide internal stakeholders with actionable medical insights from interactions with HCPs.

Explore potential new areas of interest to understand unmet needs, how the landscape is evolving, and how Kura pipeline products can address unmet needs.

Collaborate with clinical development/operations to support the potential identification of clinical trial sites/investigators and to heighten awareness of Kura late-stage company sponsored clinical trials.

Keep abreast of medical and scientific developments in the designated disease areas by continuously reviewing literature in the field, monitoring competitor activities, networking with experts and attending relevant conferences. Complete accurate and timely administrative reports, projects, and other required documentation.

Deliver approved medical/scientific presentations to internal & external stakeholders.

Support evidence generation through the facilitation of external investigator-sponsored research concept submissions.

Regularly and effectively collaborate with field colleagues (e.g., HEOR, market access, regional marketing, sales) within the assigned therapeutic area and territory to advance clinical practice while maintaining customer centricity in a compliant manner.

Support medical/scientific training of cross functional teams, as needed.

Adhere to Kura Oncology’s values and policies.

JOB SPECIFICATIONS:

PharmD/RPh, PhD, NPs, PAs, or a Master’s degree in life sciences with clinical research experience

3+ years of field experience in the biotech or pharmaceutical industry, oncology/hematology launch experience preferred

Oncology/Hematology experience with established relationships with KOLs in therapeutic areas of interest (i.e. AML)

Strong interpersonal, presentation and communication skills and demonstrated ability to work collaboratively in a dynamic, team-oriented environment

Demonstrated self-starter and collaborative team player with strong interpersonal skills

Ability to interpret key scientific data and translate findings to meet educational and research needs

Able to ensure compliance with corporate rules and government regulations

Willingness to travel up to 50% of the time, including overnight and weekends

The base range for an MSL is $218,000 - $247,000 and a Senior MSL is $243,000 - $278,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.

#LI-RM1

Kura’s Values that are used for candidate selection and performance assessments:

We work as one for patients

We are goal-focused and deliver with excellence

We are science-driven courageous innovators

We strive to bring out the best in each other and ourselves

The Kura Package

Career advancement/ development opportunities

Competitive comp package

Bonus

401K + Employer contributions

Generous stock options

ESPP Plan

20 days of PTO to start

18 Holidays (Including Summer & Winter Break)

Generous Benefits Package with a variety of plans available with a substantial employer match

Paid Paternity/Maternity Leave

In-Office Catered lunches

Home Office Setup

Lifestyle Spending Stipend

Commuter Stipend (Boston Office)

Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!

Kura Oncology is a commercial-stage biopharmaceutical company committed to discovering and developing innovative precision medicines to help patients with cancer lead better, longer lives.

Through our deep understanding of cancer biology and decades of experience in precision oncology, we are studying the underlying causes of treatment resistance. This enables us to design smart combination regimens with other cancer therapies to target tumors from multiple directions, with the goal of improving long-term clinical benefit.

Kura developed and is commercializing KOMZIFTI® (ziftomenib), the FDA-approved once-daily, oral menin inhibitor for the treatment of adults with relapsed or refractory NPM1-mutated acute myeloid leukemia, and continues to pioneer advancements in menin inhibition and farnesyl transferase inhibition. For additional information, please visit Kura’s website at www.kuraoncology.com and follow us on X and LinkedIn .

Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.

If you are a California resident, please see the attached Privacy Notice CA Privacy Notice